블로그
- 머크 몰누피라비르 3상 중간결과 발표 공동으로 진행하기 위해 제휴하기로 했다는 내용 https://theprint.in/health/molnupiravir-helps-in-faster-recovery-of-mild-covid-patients-says-hetero-after-phase
- [공유] Inovio surges as Oppenheimer cites differentiated vaccine platform 좋음 - 요약하면, 코로나19 백신, 상온보관 장점, 다른 DNA 백신 파이프라인 및 플랫폼도 관심 가져야함 The thesis mainly highlights Inovio’s COVID Phase 2/3 (INNOVATE) trial.
- 10 things you need to know today: May 18, 2020 Governors continue push to reopen as COVID-19 deaths near 90,000 Governors are pressing forward with The state plans to announce the second phase of its reopening on Monday. New York Gov.